Overview
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Status:
Completed
Completed
Trial end date:
2021-09-30
2021-09-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Altamash Institute of Dental MedicineTreatments:
Pentoxifylline
Triamcinolone
Vitamin E
Criteria
Inclusion Criteria:- Patients with clinically diagnosed OSMF who have not undergone any treatment of OSMF
in past
- Patients willing to quit their tobacco chewing habit, gutkha areca nut smoking
- Patients who are ready to attend regular follow-ups
Exclusion Criteria:
- Patients who have undergone any treatment for OSF in past
- Patients with any evidence of cardiac, gastrointestinal, kidney, metabolic disorders,
pregnant and lactating women's
- Patients with any co-existing disorder of the orofacial region other than OSF which
may interfere with the study protocol